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The mammalian central nervous system is a complex neuronal network consisting of
a diverse array of cellular subtypes generated in a precise spatial and temporal pattern
throughout development. Achieving a greater understanding of the molecular and genetic
mechanisms that direct a relatively uniform population of neuroepithelial progenitors into
diverse neuronal subtypes remains a signiﬁcant challenge. The advent of pluripotent
stem cell (PSC) technology allows researchers to generate diverse neural populations in
vitro. Although the primary focus of PSC-derived neural cells has been their therapeutic
potential, utilizing PSCs to study neurodevelopment is another frequently overlooked and
equally important application. In this review, we explore the potential for utilizing PSCs
to study neural development. We introduce the types of neurodevelopmental questions
that PSCs can help to address, and we discuss the different strategies and technologies
that researchers use to generate diverse subtypes of PSC-derived neurons. Additionally,
we highlight the derivation of several thoroughly characterized neural subtypes; spinal
motoneurons, midbrain dopaminergic neurons and cortical neurons. We hope that this
review encourages researchers to develop innovative strategies for using PSCs for the
study of mammalian, and speciﬁcally human, neurodevelopment.
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INTRODUCTION
How the highly organized human nervous system arises from a
relatively uniform population of neural progenitors remains one
of the most fascinating and challenging questions in neurobi-
ology. Progress has been made toward understanding many of
the key signaling pathways responsible for patterning the devel-
oping mammalian nervous system. However, the molecular and
genetic fate-determining mechanisms that give rise to the diver-
sity of different neural cell types are poorly understood. The
ability to manipulate gene expression in lower vertebrates is an
invaluable tool for examining mammalian neurodevelopment,
but studying the inimitable process of human neurodevelopment
is signiﬁcantly more complicated. This problem persists because
obtaining human embryonic tissue is difﬁcult and animal models
seldom completely recapitulate human developmental programs.
A more comprehensive technique for studying development of
the mammalian (and in particular human) nervous system would
lead to a greater understanding of both normal neurodevelop-
ment and provide insight into the pathophysiologies of numerous
neurodevelopmental diseases.
Over the last decade, pluripotent stem cells (PSCs) have
emerged as powerful tools with the potential to further illuminate
key mechanisms underlying neuronal development. The advent
of embryonic stem cell (ESC) and induced pluripotent stem cell
(iPSC) technologies has facilitated the analysis of the develop-
ing nervous system on a cellular and molecular level that was
previously unattainable. Several recent reviews have focused on
stem cell pluripotency and cellular reprogramming (Hochedlinger
and Plath, 2009; Hanna et al., 2010; Stadtfeld and Hochedlinger,
2010) and the potential for PSC- and iPSC-derived neural cells
to treat neurological disease (Kim and de Vellis, 2009; Marche-
tto et al., 2010; Aboody et al., 2011; Cundiff and Anderson, 2011;
Gaspard and Vanderhaeghen, 2011). In this review, we focus the
recent advances in the application of PSCs as model systems for
studying normal brain development.We will examine the types of
questions that PSCs can address, and the advantages and disad-
vantages of using PSCs for studying neurodevelopment. Guided
by the developing embryo, we will summarize the different PSC
differentiation techniques and geneticmanipulations that are used
to generate distinct neural subtypes, and highlight several in more
detail.
TYPES OF PLURIPOTENT STEM CELLS
The fusion of sperm and egg produces totipotent stem cells that
can differentiate into all known cell types. As development pro-
ceeds, cells progress from a totipotent state to more restricted
lineages such as PSCs (the ability to differentiate into any of the
three germ layers), multipotent stem cells (more restricted cell
fates), and unipotent cells (can only produce one cell type). PSCs
are capable of self-renewal, meaning that given the appropriate
conditions, they can proliferate while maintaining identical fate
potential to the parent cell. The ﬁrst PSCs to be isolated were ESCs
from the inner cell mass of themouse blastula (mESCs; Figure 1A;
Evans and Kaufman, 1981; Martin, 1981), which differentiated
into all three germ layers upon transplantation. In addition to
mESCs, stem cells have also been generated from the mouse epi-
blast after implantation, referred to asmEpiSCs (Brons et al., 2007;
Tesar et al., 2007). Although mEpiSCs display many characteris-
tics similar to mESCs, their molecular proﬁle represents that of
a more speciﬁed cell type, and their potency is more restricted.
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FIGURE 1 | Schematic depicts the origin of embryonic stem cells from
the inner cell mass of the blastocyst (A), the stem cell niches in the
subventricular zone and the hippocampus in the adult mouse brain
(B), and the induced pluripotent stem cells and induced neural cells
derived from human fibroblasts (C).
In the late 1990s the ﬁrst human ESCs (hESCs) were generated
(Thomson et al., 1998). Interestingly hESCs have different gene
expression proﬁles compared to mESCs (Ginis et al., 2004), and
appear to be functionally more similar to mEpiSCs than mESCs
(Tesar et al., 2007). Since studying human neurodevelopment at
the cellular andmolecular level presents signiﬁcant technical chal-
lenges, hESCs open the door to many experimental possibilities
that were previously impossible.
In addition to ESCs, the maintenance and repair of adult tis-
sue is achieved by niches of adult stem cells. In the brain, adult
neural stem cells (NSCs) can give rise to neurons, astrocytes, and
oligodendrocytes. There are two active zones of neurogenesis in
the adult brain: the subventricular zone (SVZ) of the lateral ven-
tricle gives rise to neurons that populate the olfactory bulb, and
the subgranular zone (SGZ) of the dentate gyrus gives rise gran-
ule cells that integrate into the hippocampal circuitry (Figure 1B;
Zhao et al., 2008). While adult stem cells may provide important
insights into aspects of neurodevelopment, ESCs are the primary
stem cell tool for studying neurodevelopment.
More recently, researchers have discovered how to reprogram
both mouse (Takahashi and Yamanaka, 2006) and human (Taka-
hashi et al., 2007; Yu et al., 2007) somatic cells into iPSCs
(Figure 1C). This was initially achieved by introducing retro-
viruses engineered to express four genes that mediate the repro-
gramming to pluripotency. Improved techniques for somatic cell
reprogramming to PSCs include the genetic excision of virally
introduced programming factors, small molecules that reactivate
quiescent transcription factors to induce pluripotency, utilization
of transposons to reprogram cells, syntheticmodiﬁedmRNAs that
do not alter the cell’s genome, and microRNAs (miRNAs; Miyoshi
et al., 2011; Sidhu, 2011). iPSCs have several advantages over
ESCs, such as the ability to create patient-speciﬁc human iPSC
lines and reduced ethical concerns since their generation does
not involve the destruction of human blastocyst stage embryos.
iPSCs and ESCs have a well-deﬁned core pluripotency genetic
network in common. However, several recent studies found that
iPSCs contain increased somatic mutations (Gore et al., 2011),
increased copy number variations (Hussein et al., 2011), and sig-
niﬁcant variability in DNA methylation and epigenomic events
(Lister et al., 2011) as compared to both their ﬁbroblast origin
cells and hESCs. These issues have raised concerns regarding the
potential limitations of iPSCs to study disease. However,many dif-
ferent iPSC lines can be differentiated into motor neurons (MNs)
using a standard differentiation protocol (Boulting et al., 2011),
providing hope that iPSC lines with signiﬁcant genetic and epi-
genetic variability may display similar differentiation potential.
Thus, iPSCs have tremendous potential for both therapeutics and
for the elucidation of developmental processes, but the safety of
iPSCs and the mechanisms of reprogramming require further
investigation.
To circumvent this reprogramming step,numerous groups have
bypassed the PSC stage and successfully converted mouse and
human ﬁbroblasts directly into functional neurons, called induced
neural cells (iNs; Figure 1C). Initial studies identiﬁed ∼3–5 crit-
ical transcription factors that could be overexpressed to directly
convert ﬁbroblasts to neurons (Vierbuchen et al., 2010; Pang et al.,
2011), whereas others used combinations of miRNAs and tran-
scription factors (Ambasudhan et al., 2011; Yoo et al., 2011).
The ability to derive speciﬁc neural subtypes from iNs remains
unclear, although several groups have generated dopaminergic
iNs (Caiazzo et al., 2011; Pﬁsterer et al., 2011) and motor neuron
iNs (Son et al., 2011). An alternate strategy is to convert ﬁbrob-
lasts directly to neuronal progenitors (rather than PSCs or mature
neurons),which could retain the ability to differentiate intomulti-
ple subtypes (Kim et al., 2011a). Additionally, patient-speciﬁc iNs
could be generated to enhance the study of developmental disor-
ders and other neurological diseases (Qiang et al., 2011). Thus,
the signiﬁcant decrease in time and resources to derive neurons
directly from somatic cells justiﬁes further investigation into this
strategy.
STRUCTURE AND DERIVATION OF THE DEVELOPING
NERVOUS SYSTEM
ORGANIZATION OF THE DEVELOPING NERVOUS SYSTEM
In order to direct PSCs toward a neuronal fate in vitro, one
must understand the basic cellular organization and patterning
factors within the developing embryonic nervous system (for
review see Martin, 2003). The gastrula is a tri-layered struc-
ture comprised of three germinal layers: endoderm (primordial
viscera), mesoderm (primordial bones/muscles), and ectoderm
(primordial nervous system and skin). The neural plate is a
ﬂat sheet of ectodermal cells (the neuroepithelium) that evagi-
nates over time and fuses dorsally to form a cylinder of cells
known as the neural tube. Throughout its rostro-caudal axis,
the neural tube contains multipotent NSCs that generate both
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neurons and glia of the central nervous system (CNS). The periph-
eral nervous system (PNS) is derived from the neural crest, a
population of cells that emerges from the dorsal neural tube
and migrates peripherally. Subsequently, three primary vesicles
develop in the rostral portion of the neural tube: the prosen-
cephalon (forebrain), mesencephalon (midbrain), and rhomben-
cephalon (hindbrain). The caudal neural tube remains undif-
ferentiated and will form the mature spinal cord. Secondary
vesicles emerging from the prosencephalon give rise to the telen-
cephalon (cerebral hemispheres) and diencephalon (thalamus and
hypothalamus).
NEURAL INDUCTION AND PATTERNING THE NEURAXIS
How does the relatively simple gastrula initiate neural induction
and give rise to many distinct regions of the CNS, which then
produce a vast array of neural subtypes? The ﬁrst molecules that
play a role in specifying neural fates during gastrulation were dis-
covered in a series of studies in Xenopus in the 1990s (reviewed
in Munoz-Sanjuan and Brivanlou, 2002; Stern, 2005; Levine and
Brivanlou, 2007). Bonemorphogenetic proteins (BMPs) andWnts
are secreted factors that suppress the neural induction of ecto-
derm and promote an epidermal lineage. The gastrula organizer is
a group of cells that express BMP inhibitors to suppress epidermal
differentiation and initiate neural induction. Thus, neural induc-
tion primarily requires inhibition of non-neural fates by block-
ing neural inhibitors (a double negative), raising the hypothesis
that neural fates are a default mechanism that must be over-
come by progenitor cells to differentiate into other tissue types
(Munoz-Sanjuan and Brivanlou, 2002).
The initial patterning of the CNS is achieved using a relatively
small number of evolutionarily conserved signaling factor fami-
lies that are expressed as gradients along the rostro-caudal (R-C,
also called the anterior–posterior or A–P axis) and dorsal–ventral
(D–V) axis (Figure 2). The same signaling molecule can induce
different effects depending upon its concentration, temporal and
spatial expression pattern, and the presence of various receptor
subfamilies and modulating factors. For example, although BMPs
and Wnts initially inhibit neural induction, BMPs, and Wnts are
expressed throughout the dorsal portion of the neuraxis and are
required for the formationof dorsal neural tissue (Liu andNiswan-
der, 2005; Ulloa and Marti, 2010). Ventralization of the neuraxis
is primarily directed by the morphogen Sonic hedgehog (Shh),
which is secreted at the ventral midline of the neural tube by a
specialized structure known as the ﬂoor plate (and the underlying
non-neuronal notochord) that spans the entire R-C neuraxis. In
addition to Shh, much of the ventral neuraxis also expresses BMP
inhibitors that suppress BMP action.
One of the most important caudalizing molecules is retinoic
acid (RA). RA is present at high levels in the primitive spinal
cord and, in combination with ﬁbroblast growth factors (FGFs), is
required for patterning the different spinal cord segments (Maden,
2006). Wnts are also expressed in the caudal portion of the
neuraxis, and Wnt antagonists are expressed by cells along the
rostral axis. Additionally, a patch of cells located at the midbrain–
hindbrain boundary (the isthmic organizer) secretes FGF8, an
important signal for regulating development of midbrain and
hindbrain structure (Partanen, 2007).
FIGURE 2 | Schematic depicts important secreted signaling factors that
pattern the rostro-caudal and dorso-ventral neuraxis during embryonic
development. A coronal section through the developing telencephalon is
depicted (dotted line, arrow). BMP, bone morphogenetic protein; FGF,
ﬁbroblast growth factor; RA, retinoic acid; Shh, Sonic hedgehog
Thus, the fate of an individual neuron depends upon its spatial
position along the neuraxis, temporal birthdate, genetic proﬁle,
and the patterning factors expressed by neighboring cells. It is
therefore logical that PSCs can be differentiated toward many
different neural subtypes by modulating exogenous levels of (or
intrinsic responses to) BMP, Wnt, Shh, FGF, and other relevant
signaling pathways (Figure 3).
NEURODEVELOPMENTAL QUESTIONS THAT MAY BE
ADDRESSED USING PSCs
As the PSC ﬁeld is still in its infancy, many studies focus on devel-
oping efﬁcient protocols for optimizing the derivation of distinct
neuronal cell types (Table 1). The challenge is to harness this
potential to address speciﬁc questions of neurodevelopment.
NEUROGENESIS AS A DEFAULT MECHANISM
As mentioned above, evidence from the developing embryo sup-
ports a model whereby ectodermal tissue becomes speciﬁed to a
neural identity by default (Munoz-Sanjuan and Brivanlou, 2002).
ESC differentiations in vitro are an ideal tool to more closely
examine this theory, but the variety of distinct culture techniques
can produce different results. Culturing mESCs in a chemically
deﬁned serum-free medium as low-density aggregates is sufﬁcient
to induce differentiation into neural cells without exogenous fac-
tors (Tropepe et al., 2001; Smukler et al., 2006;Gaspard et al., 2008).
When grown as adherent monolayers, mESCs required the addi-
tion of FGF for neural induction (Ying et al., 2003). Another study
developed a protocol in which mESCs cultured in the absence
of any extrinsic factors produced ∼80% Sox1+ cells, a marker
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FIGURE 3 | Schematic depicts the general procedure for deriving
different neuronal subtypes from PSCs by utilizing secreted patterning
factors identified in the developing embryo. BMP, bone morphogenetic
protein; FGF, ﬁbroblast growth factor; RA, retinoic acid; Shh, Sonic
hedgehog.
of neural progenitors, but inhibiting Wnt and Nodal signaling
increased it to∼90% (Watanabe et al., 2005).More detailed analy-
sis revealed that the lack of extrinsic cues appears to drive mESCs
to an anterior/forebrain fate (Watanabe et al., 2005; Gaspard et al.,
2008), in agreement with the lack of instructive cues to rostral-
ize the neural tube during embryonic development (Figure 2).
However, removal of KSR and insulin from the culture medium
may promote a hypothalamic cell fate (Wataya et al., 2008). Addi-
tionally, in one instance, MNs were derived from mESCs grown
at a low-density in the absence of added factors (Peljto et al.,
2010), highlighting that subtle changes in medium composition
and culture techniques can have signiﬁcant effects on fate and
differentiation efﬁciency.
Similar ﬁndings have been demonstrated for hESCs. hESCs
grown as embryoid body-like aggregates in the absence of feeder
cells and exogenous cues produced ∼35% Pax6+ cells (a dorsal,
“pallial” telencephalicmarkerwhen co-expressedwith FoxG1), but
addition of Wnt,Nodal, and BMP inhibitors boosted this percent-
age to∼75% Pax6+ cells (Watanabe et al., 2007). Multiple studies
found that hESCs and hiPSCs are driven toward a neural fate when
cultured in the presence of inhibitors of SMAD signaling (nog-
gin and SB431542), a downstream transducer of TGFβ activity
(Pera et al., 2004; Smith et al., 2008; Chambers et al., 2009). Thus,
these data generally support the “default model”; ESCs undergo
neural induction in vitro without instruction from extrinsic fac-
tors, and simply blocking inhibitors of neural fate can further
enhance neurogenesis.
TEMPORAL SPECIFICATION OF NEURAL CELL TYPES
Pluripotent stem cell-derived neurons can be used to study the
temporal speciﬁcation or differentiation process of neuronal sub-
types. Neural speciﬁcation is often determined by differential
responses of receptor cells to a gradient of a given signaling mol-
ecule. Thus, subtle changes in the concentration or timing of
exogenous factors can have a dramatic effect on cell type spec-
iﬁcation. For example, in hESCs using identical differentiation
protocols, early Shh exposure produces ﬂoor plate tissue while
later Shh exposure induces telencephalic progenitors (Fasano et al.,
2010).While this is a dramatic change in cell fate, one could exam-
ine more subtle fate effects. In one protocol, a moderate increase
in Shh concentration (from 10 to 30 nM) can shift ESCs from
and LGE-like to an medial ganglionic eminence (MGE)-like fate
(Danjo et al., 2011).
Neurogenesis in the developing cortex occurs in a predictable
temporal manner with the sequential generation of speciﬁc neural
subtypes: preplate neurons such as Cajal–Retzius cells are born
ﬁrst, and then deep cortical layers followed by more superﬁ-
cial layers. There are speciﬁc temporal markers for each of these
cell types, allowing for the characterization of maturing PSC-
derived neurons in a temporal fashion. It was previously shown
that individual cortical progenitors plated in culture undergo
repeated asymmetric divisions to produce a variety of neu-
ronal cell types that mimic the normal differentiation sched-
ule in vivo (Shen et al., 2006). This pattern also holds true
for mESC differentiations in vitro. When mESCs are cultured
in the absence of serum or extrinsic factors (except for a Shh
inhibitor), they sequentially generate cortical neurons that grossly
recapitulate the temporal pattern of normal development (Eiraku
et al., 2008; Gaspard et al., 2008). A similar ﬁnding was demon-
strated with mESC-derived retinal cells. Amazingly, ﬂoating EBs
can develop optic cup-like structures that give rise to different
retinal cells in a temporal manner that mimics their develop-
mental time course in vivo (Eiraku et al., 2011). Thus, mESCs
(and potentially hESCs) may provide a simpliﬁed, reduction-
ist approach for studying the temporal patterning of cortical
development.
IDENTIFICATION OF NOVEL GENES AND MOLECULES THAT SPECIFY
NEURONAL FATE DETERMINATION
The fact that distinct CNS regions, and individual neuronal
progenitors within these regions, can give rise to a wide vari-
ety of cell types in vivo presents a challenge for understand-
ing how individual genes determine neuronal fate speciﬁca-
tion. The ability to generate and isolate a homogeneous pop-
ulation of neurons in vitro can better address this question.
One can purify a speciﬁc PSC-derived population of cells and
perform microarrays or transcriptome sequencing at different
time points to identify novel genes and relevant signaling path-
ways that are important for fate speciﬁcation, as was done
for hESC-derived ﬂoor plate cells (Fasano et al., 2010). Addi-
tionally, small molecule screens can be conducted to identify
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Table 1 |Table details the many different neural cells that have been derived from PSCs to date, specifying the type of PSC, the key exogenous
signaling factors, the markers used to verify cell type specificity, and the corresponding references.
Differentiated CNS
neural subtype
PSC type Key patterning factors used
in PSC differentiation
Genes used to verify
cell types
References
Spinal cord motor neurons mESCs, hESCs,
iPSCs
Shh, RA, SB431542 Pax6, Nkx6.1, Olig2,
HB9, Hox genes,
Islet1/2, ChAT, Lhx6,
FoxP1, Pea3, Scip
Wichterle et al. (2002), Li et al.
(2005), Soundararajan et al. (2006),
Lee et al. (2007), Dimos et al. (2008),
Peljto et al. (2010), Patani et al. (2011)
Spinal cord interneurons mESCs Wnt3A, Shh, RA, BMP2 Lim2, GAD67, GLUT Murashov et al. (2005)
Cortical pyramidal neurons mESCs, hESCs Cyclopamine, FGF2, RA Nestin, RC2, glutamate,
TUJ-1, MAP2
Eiraku et al. (2008), Gaspard et al.
(2008), Gaspard et al. (2009),
Ideguchi et al. (2010)
Cortical interneurons mESCs Shh, Fgf2, IGF Nkx2.1, Lhx6, PV, Sst,
NPY
Maroof et al. (2010), Danjo et al.
(2011), Goulburn et al. (2011)
Cerebellar granule neurons mESCs, hESCs WNT1, FGF8, RA, BMP6/7,
GDF7, Shh, JAG1
Math1, Meis1, Zic1,
En1, cyclin D2, Pax2/6,
GABAα6r Zic2
Salero and Hatten (2007), Erceg et al.
(2010)
Cerebellar Purkinje cells mESCs BMP4, Fgf8 Math1, L7,
calbindin-D28K
Su et al. (2006), Tao et al. (2010)
Hypothalamic neurons mESCs gfCDM, Shh Rax, Six3, Vax1, Otp,
Brn2
Wataya et al. (2008)
Basal forebrain cholinergic
neurons
hESCs RA, bFGF, FGF8, Shh, BMP9 ChAT, AChE, p75 Bissonnette et al. (2011)
Midbrain dopaminergic
neurons
mESCs, hESCs,
iPSCs
Shh, AA, FGF8, bFGF Otx2, Pax2, Pax5,
Wnt1, En1, Nurr1, TH
Kawasaki et al. (2000), Lee et al.
(2000), Perrier et al. (2004),Yan et al.
(2005), Chambers et al. (2009)
Striatal medium spiny
neurons
mESCs, hESCs Shh, BDNF, DKK1, cAMP,
valproic acid
Gsh2, Nolz1, Ctip2,
DARPP32
Aubry et al. (2008), Danjo et al. (2011)
Floor plate hESCs Shh, dual SMAD inhibition Foxa2, netrin-1, Shh,
F-spondin, Six6, Lmx1b,
En1, Ngn2
Fasano et al. (2010)
Neural crest hESCs, hiPSCs SB431542, noggin Hnk1, AP2, pheriperin,
Mash1, Brn3a, GFAP,
Sox10, CD73
Lee et al. (2010)
General telencephalic
neurons
mESCs DKK, LeftyA,Wnt3a, Shh Foxg1, Pax6, Nkx2.1,
Islet1/2
Watanabe et al. (2005), Li et al.
(2009)
Dorsal telencephalon mESCs, hESCs SFEBq culture Ctip2, Foxg1, TBr1,
synaptophysin
Eiraku et al. (2008)
Retinal neurons mESCs, hESCs RA, FGF, Dkk, LeftyA, HA, IST,
T3
Pax6, Otx2, Chx10, Rax,
Brn3b, Otx1, Ctip2,
recoverin, rhodopsin
Ikeda et al. (2005), Lamba et al.
(2006), Osakada et al. (2008), Nistor
et al. (2010), Eiraku et al. (2011)
compounds that enhance the derivation of distinct cell types.
Improvements in the speciﬁcity and efﬁciency of differentiation
protocols should lead to a signiﬁcant increase in these types of
studies.
POST-MITOTIC DEVELOPMENT
Pluripotent stem cell-derived neurons are an excellent tool for
studying aspects of post-mitotic neuronal maturation, such as
cell migration, axiogenesis, dendritogenesis, target recognition,
synaptogenesis, and proper integration into neuronal circuitry. A
common technique is to purify ﬂuorescently labeled PSC-derived
neurons and transplant them into host environments to verify
that they form synapses (Maroof et al., 2010; Danjo et al., 2011).
In addition to being a crucial aspect of protocol veriﬁcation, this
procedure provides a mechanism to study various developmental
aspects of a neuron in its endogenous environment. One can
visualize transplanted cells in real time, compare gene expression
in ﬂuorescently labeled cells with their endogenous neighbors,
and evaluate their synaptogenesis and integration into the cor-
tical circuitry using electrophysiological recordings. In addition to
transplantation studies, PSC-derived neurons can also be plated
on speciﬁc feeder cells to study synaptogenesis in vitro (Brennand
et al., 2011; Kim et al., 2011b). The ability to manipulate gene
expression in PSCs allows one to characterize a role for speciﬁc
genes in distinct processes of neuronal maturation. Put simply,
generating an unlimited source of PSC-derived neural subtypes
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can open the door to many possible experiments examining
neuronal maturation.
EFFECT OF EXOGENOUS FACTORS ON NEURAL DEVELOPMENT
Another less appreciated use of PSCs is the derivation of neural
progenitors from PSCs to study the effects of exogenous factors on
neural development. For example, ethanol consumption during
pregnancy can have wide ranging effects on many aspects of brain
development, making it a difﬁcult to determine the exact mecha-
nism of ethanol’s effect. A recent study found that hESCs exposed
to ethanol during neuronal differentiation impaired the survival,
morphology, gene expression, and differentiation capabilities of
neural progenitors (Talens-Visconti et al., 2011). There is a grow-
ing ﬁeld of developmental toxicology studies that use PSC-derived
cells to examine the effects of hazardous agents on cell survival,
proliferation, and differentiation (Wobus and Loser, 2011). For
instance, one study examined the effect of botulinum toxin on
mESC-derivedMNdevelopment (Kiris et al., 2011). These detailed
ﬁndings would be challenging to uncover from more traditional
methods, and one can envision these types of experiments being
applied to a wide range of candidate compounds that perturb
normal neuronal development.
SPECIFIC INSIGHTS INTO HUMAN DEVELOPMENT
Human ESCs and hiPSCs allow researchers to speciﬁcally investi-
gate aspects of human development that were previously unat-
tainable due to the technical and ethical concerns of studying
human fetuses. While mice (and mESCs) are good models for
studying neural development, there are clearly signiﬁcant differ-
ences between mice and humans, and thus discoveries in mice
(and mESCs) may not be directly applicable to human develop-
ment.mESCs generally differentiate toward a given neural cell type
faster than hESCs under equivalent conditions, which may be due
to differences in intrinsic kinetics or differentiation competence.
There is ample evidence that mESCs and hESCs have signiﬁcantly
different gene expression proﬁles (Ginis et al., 2004; Tesar et al.,
2007). For example, the transcription factor Pax6 is a requisite fate
determinant for neural induction of hESCs, whereas neither loss
nor gain of Pax6 function affects neural speciﬁcation in mESCs
(Zhang et al., 2010). Additionally, some protocols that are efﬁcient
at neural induction in hESCs and hiPSCs (dual SMAD inhibition;
Chambers et al., 2009) do not efﬁciently generate neurons from
mESCs (J. Tyson and S. Anderson, unpublished data).
While hPSCs hold more promise for studying human devel-
opment than mPSC-derived cells, a challenge is to develop
assays to study synaptogenesis and functional connectivity in
these cells. Long-term cultures in vitro or xenograft trans-
plants in vivo are required to thoroughly analyze the devel-
opment of hPSC-derived neurons. Additionally, since relatively
little is known about the molecular nature of human neu-
rodevelopment, it can be difﬁcult to verify whether discover-
ies made with hPSCs represent real insights into human neu-
rodevelopment or are instead artifacts of the culture system.
The Allen Institute for Brain Science has recently launched
BrainSpan, an atlas for the developing human brain consisting of
RNA sequencing, microarray analysis, and in situ hybridizations
spanning multiple brain regions at 13 different developmental
stages (http://developinghumanbrain.org/). The combination of
the developing mouse and human brain atlases are invaluable
resources for the study of human brain development.
GENETIC TECHNIQUES FOR ENHANCING PSC-DERIVED
NEURAL CELL PRODUCTION, SPECIFICATION, AND
ISOLATION
Even with well-deﬁned differentiation protocols, cultures contain
a heterogeneous population of different cell types, so having a
marker for labeling and isolating the desired cell type is crucial.
Some strategies for cell type speciﬁc puriﬁcation rely on cell sur-
face markers to sort neuronal progenitors (Pruszak et al., 2007)
For example, the forebrain surface antigen-1 (FORSE1) has been
used to isolate hESC-derived neuronal progenitors (Elkabetz et al.,
2008). The use of cell type selective promoter elements to direct
expression of ﬂuorescentmarkers is another powerful tool for efﬁ-
ciently identifying and purifying distinct PSC-derived neurons via
ﬂuorescence-activated cell sorting (FACS).
Traditional techniques for gene transfer in PSCs utilize site-
directed targeting or non-targeted insertion of promoter-driven
ﬂuorescent markers. These transgenes can be introduced into the
PSC genome via electroporation, nucleofection, or viral-mediated
delivery systems. Site-directed targeting requires homologous
recombination and should faithfully recapitulate the targeted gene
by integrating into the endogenous locus, but this process can be
labor intensive and often results in a heterozygotic phenotype.
Random insertion leaves both endogenous copies of the gene of
interest intact, but requires identiﬁcation of promoter or enhancer
structures to drive protein expression. Additionally, randomly
inserted transgenes are often dysregulated or unstable and can
disrupt expression of other genes depending on their integration
site. Several recent technologies described below show promise for
enhancing the derivation of neural cells from PSCs.
Bacterial artiﬁcial chromosomes (BACs) can be used to intro-
duce large pieces of genomic DNA (∼100–300Kb) into PSCs
via homologous recombination. BACs are advantageous because
their large size likely retains critical regulatory regions for gene
expression and limits silencing due to unwanted chromatin mod-
iﬁcations. BACs can be modiﬁed to express ﬂuorescent proteins
under the control of speciﬁc genes. BAC transgenesis into mESCs
(Tomishima et al., 2007) and hESCs (Placantonakis et al., 2009)
has facilitated the production of many ﬂuorescent-labeled ESC
lines, with a tremendous potential to modify other genes. Some
potential drawbacks to BAC transgenesis include inefﬁcient BAC
integration, disruption of endogenous gene expression at the inte-
gration site, and unwanted gene dosage effects since BACs often
contain multiple genes.
Transposons are DNA sequences that can move from one loca-
tion to another within the genome of a single cell, with the
piggyBac transposon being most active in mammalian cells (Ding
et al., 2005). The transposon system consists of a DNA sequence
ﬂanked by two terminal repeats, and a transposase enzyme that
catalyzes mobilization of the transposon to another genomic
site. Importantly, transposons can be seamlessly removed by re-
expressing the transposase, eliminating any unwanted genomic
footprint. In addition to providing a viral-free mechanism for
deriving iPSCs from ﬁbroblasts (Sidhu, 2011), transposons can
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also be used to inducibly express pro-neural genes that efﬁ-
ciently drive hESCs to differentiate toward a neuronal fate (Lacoste
et al., 2009). Combined with the improved efﬁciency of piggyBac
transposase in mammalian cells (Yusa et al., 2011), transposons
represent a highly efﬁcient technique with minimal genomic
manipulation for enhancing PSC-derived neural cells in the
future.
Finally, zinc ﬁnger nucleases (ZFNs) can induce site-speciﬁc
double-strand DNA breaks to facilitate homologous recombi-
nation for genetic manipulation in PSCs. Several zinc ﬁnger
motifs that specify a DNA recognition site are fused to a non-
speciﬁc nuclease that cleaves double stranded DNA and induces
homology-directed repair, allowing for the incorporation of
exogenous sequences into at the cleavage site. Successful demon-
stration of ZFN in hESCs was recently achieved (Lombardo et al.,
2007), and another study successfully targeted the PITX3 gene in
hESCs (Hockemeyer et al., 2009), a known marker for dopamin-
ergic neurons. While this approach signiﬁcantly improves the
efﬁciency for making ﬂuorescent reporter lines, it remains to be
seen if ZFNs can be used to enhance gene expression to promote
neural differentiation.
In addition to the above strategies for labeling PSCs, it bears
mentioning that a variety of genetic manipulation techniques can
be utilized to direct fate speciﬁcation of PSC-derived cells. One
group transfected two transcription factors into hESC-derived
neural progenitors to enhance generation of basal forebrain
cholinergic neurons (Bissonnette et al., 2011). Another promis-
ing tool is to inducibly express fate-determining genes during
PSC cell differentiations. For example, one can utilize a mESC
line modiﬁed with the reverse tetracycline transactivator system
(rtTA,“doxy-on”) system to inducibly and reversibly express genes
of interest during the differentiation protocol (Ting et al., 2005).
Other strategies that can be used to manipulate gene expression
in PSCs include using the LoxP-Cre, CreER, or FRT -Flp systems,
which provide inducible control of recombination.
The ongoing progress towards identifying novel genes
expressed in speciﬁc neuronal subtypes combined with improved
techniques for genetically modifying PSCs will greatly advance the
use of PSC-derived neurons for the study of neurodevelopment.
GENERATION OF SPECIFIC NEURAL SUBTYPES FROM PSCs
A wide variety of protocols have been developed to generate many
PSC-derived neural subtypes that span the entire neural tube
(Table 1). In this section,wewill brieﬂy summarize thePSCderiva-
tion of three of the more thoroughly investigated and clinically
relevant neuronal subtypes (Figure 4). (See the Neurogenesis as
a Default Mechanism? section for a summary of general neural
induction techniques). It is important to note that there are sig-
niﬁcant differences in protocol development, such as the media
composition, the timing and concentration of exogenous signaling
factors, cell density at plating, the adherent and feeder environ-
ment, and the physical dimensions of the culture system. While
we highlight the most important signaling factors that are used to
generate each type of neuron, the medium often contains other
growth factors and nutrients not mentioned.We recommend that
readers refer to the original studies for a more detailed description
of the protocols.
FIGURE 4 | Comparison of different techniques for deriving three of the
more studied neural cell types: spinal motor neurons (A), midbrain
dopaminergic neurons (B), and cortical cells (C). FGF, ﬁbroblast growth
factor; RA, retinoic acid; Shh, Sonic hedgehog; IGF, insulin growth factor;
AA, arachidonic acid; PN, projection neurons; IN, interneurons; MMC,
median motor neurons; LMC, lateral motor neurons; HMC, hypaxial motor
neurons; DA, dopaminergic.
SPINAL MOTOR NEURONS
In the developing embryo, MNs are generated from neural prog-
enitors in the ventral portion of the spinal cord. A combinatorial
code involving the Hox family of transcription factors establishes
the identity of multiple MN pools located throughout the longi-
tudinal axis of the spinal cord (Dasen and Jessell, 2009). Mature
MNs in vivo adopt one of three columnar fates; either the median
(MMC), hypaxial (HMC), or lateral (LMC) motor column. These
three motor columns can be further divided into subgroups cate-
gorized by the individual cells’ spatial position,molecular identity,
and musculature innervations. Optimizing protocols to generate
different types of PSC-derivedMNs will be beneﬁcial for studying
both normal neural development and therapeutic applications for
MN diseases.
Since the derivation of MNs from PSC requires caudalization
and ventralization of neural progenitors, the two likely candidates
for inducing this identity are RA and Shh, respectively (Figure 4A;
Wichterle et al., 2002). After the caudalizing action of RA, Shh sig-
naling promotes MN fate deﬁned by the expression of several MN
markers including HB9, which is selectively expressed by MNs
in vivo. Upon transplantation into chick spinal cord, HB9::GFP
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mESC-derived MNs project axons along endogenous MN axon
pathways and form synapses on the corresponding muscle targets
(Wichterle et al., 2002). Using this strategy, most mESC-derived
MNs express the cervical MMC marker Lhx3 (Wichterle et al.,
2002; Soundararajan et al., 2006). While most studies utilize RA
and Shh to generate MNs, efforts to generate other MN fates have
utilized retinoid-independent techniques (Patani et al., 2011). A
recent study derived LMCMNs by eliminating exogenous RA and
Shh from the protocol and instead relying on endogenous signal-
ing hubswithin EBs (Peljto et al., 2010). Furthermore, late addition
of exogenous RA induced post-mitotic MNs to a lateral LMC
fate. Thus, although growing PSCs in serum-free, morphogen-
free conditions tends to promote anterior neural fates, this is an
example where slight modiﬁcations in the medium and culture
conditions can give rise to different cell fates and induction efﬁ-
ciencies. Further protocol optimization will likely improve our
ability to generate homogenous populations of different speciﬁc
MN subtypes.
More recently, protocols utilizing RA and Shh have been devel-
oped to generate MNs from hESCs (Li et al., 2005; Di Giorgio
et al., 2008) and iPSCs (Dimos et al., 2008). The iPSC study used
ﬁbroblasts taken from patients with amyotrophic lateral sclerosis
(ALS) and healthy controls, and demonstrated that the ALS iPSCs
could differentiate intoMNs in vitro, highlighting the potential for
using iPSCs to study neurological diseases. Taken together, these
ﬁndings suggest that one can recapitulate fundamental biological
principles of MN development and maturation in vitro, reinforc-
ing the notion that PSCs provide a system to analyze mechanisms
of normal and abnormal human neurodevelopment.
MIDBRAIN DOPAMINERGIC NEURONS
Dopaminergic (DA) neurons are found in many brain regions,
but the most prominent groups of DA neurons occupy the sub-
stantia nigra and ventral tegmental area of the midbrain. Degen-
eration of midbrain DA neurons is one of the hallmarks of
Parkinson’s disease, and thus developing methods to derive DA
neurons from PSCs has signiﬁcant therapeutic potential. Much
like PSC-derived MNs, the successful conversion of PSCs into
midbrain DA neurons in vitro is dependent on the signaling
factors used to induce genes expressed in endogenously devel-
oping DA neurons. As mentioned above, FGF8 is an impor-
tant patterning factor for the midbrain and hindbrain regions
(Partanen, 2007). The ventral location of midbrain DA neu-
rons implies that Shh may also play a prominent role in their
derivation.
In 2000, two separate studies utilizing distinct protocols suc-
cessfully derived DA cells from mESCs. One study treated dissoci-
atedmESCswith Shh,FGF8,and ascorbic acid to generate cells that
expressed a variety of midbrain DA markers and conﬁrmed that
these cells released dopamine into the medium (Lee et al., 2000).
A second study generated DA neurons simply by growing mESCs
on stromal cells in the absence of any patterning factors, and these
cells survived upon transplantation into themouse striatum, indi-
cating that they are more likely forebrain rather than midbrain
DA neurons (Kawasaki et al., 2000). Strikingly, these two drasti-
cally different protocols both reported that ∼30% of Tuj-1+ cells
(a neuronal marker) expressed the dopaminergic marker tyrosine
hydroxylase (TH). A later study utilized Shh and FGF8 to pro-
duce hESC-derived midbrain DA neurons, noting that early FGF8
treatment produced midbrain DA neurons whereas later FGF8
treatment resulted in cells that weremore likely forebrain DA neu-
rons (Figure 4B; Yan et al., 2005). Additionally, Shh, FGF8, and
ascorbic acid were utilized to drive hESCs and iPSCs to midbrain
DA neurons using the feeder-free, dual SMAD inhibition protocol
mentioned above (Chambers et al., 2009). Transplantation of both
mESC-derived (Kim et al., 2002) and hESC-derived (Roy et al.,
2006) midbrain DA neurons have shown promise in ameliorat-
ing some of the motor defects in rodent models of Parkinson’s,
although signiﬁcant work is required to ensure the long-term
efﬁcacy and safety of this technique.
CORTICAL NEURONS
As mentioned above, PSCs that are differentiated either as EBs,
adherent monolayers, or co-cultures with stromal cells and then
expanded in serum-free media without exogenous patterning
factors predominantly generate forebrain progenitors expressing
the telencephalic marker FoxG1 (also known as BF1). Notably,
many of these progenitors give rise to cortical pyramidal neurons,
which can be partially attributed to endogenous Wnt signaling
that represses Shh signaling (Li et al., 2009). Generation of corti-
cal pyramidal neurons is further enriched when the ventralizing
action of the morphogen Shh is inhibited (Figure 4C; Gaspard
et al., 2008). mESC- and hESC-derived forebrain progenitors are
capable of forming 3D structures with an apical–basal polarity
and organized cellular layers reminiscent of cortical development
in vivo (Eiraku et al., 2008). These cells are similar to their in vivo
equivalents in morphology, neurotransmitter proﬁle, expression
of cortical layer markers and precise axonal projections upon
transplantation in vivo.
Cortical pyramidal neurons have a wide variety of cortical and
subcortical targets depending on their location and functional
modality, and there are both intrinsic and extrinsic mechanisms
that regulate this organization (O’Leary et al., 2007). Initial studies
found that many ESC-derived neural progenitors would develop
into cortical pyramidal cells and integrate into the cortical cir-
cuitry when transplanted into the lateral ventricles of mice and
rats (Wernig et al., 2004; Muotri et al., 2005). More detailed stud-
ies characterized the speciﬁc connectivity of these cells. In one
instance, ESC-derived cortical pyramidal cells transplanted into
the frontal cortex adopted projection patterns resembling that
of visual and limbic occipital cortical projection neurons (and
expressed the occipital cortical markers CoupTFI and CoupT-
FII), indicating that fates of these cells were determined in vitro
(Gaspard et al., 2008). Conversely, another study found that ESC-
derived pyramidal cells developed dendritic and axonal connec-
tivity that were appropriate for their transplanted location into the
somatosensory, visual, or motor cortices, implying that the fate of
these cells was still inﬂuenced by environmental factors (Ideguchi
et al., 2010).
GABAergic interneurons comprise ∼20% of all cortical cells
and are important modulators of cortical activity. While cortical
pyramidal cells originate from the dorsal telencephalon, cortical
interneurons are born in the ventral telencephalon, speciﬁcally the
MGEand caudal ganglionic eminence (CGE),andmigrate dorsally
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into the cortical plate. Two recent studies have developed protocols
to differentiate mESCs into cortical interneurons by adding the
ventralizing agent Shh to the culture medium upon neural induc-
tion (Figure 4C;Maroof et al., 2010;Danjo et al., 2011). These cells
express characteristic interneuronal neurochemical and electro-
physiological properties when transplanted into postnatal cortices
(Maroof et al., 2010). Modulation of FGF signaling can alter the
balance between MGE- and CGE-derived interneuron subgroups
(Danjo et al., 2011).
The details of how exactly intrinsic expression proﬁles act
in combination with extrinsic functional inputs to produce the
diverse array of cortical pyramidal and interneuron subgroups
remains unclear. Therefore using PSC-based strategies to deﬁne
the intrinsic genetic programs and corresponding temporal pat-
terning signals inmaturing progenitors in vitro could help uncover
signaling pathways involved in human cortical development
in vivo.
CONCLUSION
The ability to generate PSC-derived neural cells that faithfully
recapitulate normal embryonic development enables the study
of mammalian neural development, and in particular human,
in a more accessible manner then has previously been achieved.
Rapid progress is being made in manipulating gene expression
in PSCs and improving techniques for generating, isolating and
studying diverse populations of neural subtypes. For example,
efforts are underway for PSC-derived neural cells to more faith-
fully recapitulate in vivo development using bioreactors and 3D-
scaffolds to improve organized cell migration and axon extension
in the dish, as well improved reproducibility over conditions
such as temperature, pH and oxygen levels, nutrient replace-
ment, and ﬂow rate of the media (Ghasemi-Mobarakeh et al.,
2008; Dalton and Mey, 2009). These types of advances will aid
in deﬁning molecular mechanisms controlling the establishment
of the complex and precise neuronal connectivity during CNS
development. Like all emerging scientiﬁc endeavors, signiﬁcant
hurdles remain in expanding the use of PSCs to study neural
development.
First, there is considerable diversity and nuances within PSC
culture techniques, making it unclear how reproducible differen-
tiation protocols are between labs. For example, differentiation
techniques that are efﬁcient for ﬂoating embryoid bodies might
not translate well to adherent dissociated PSC cultures. This lack
of uniformity is one of the driving forces for developing novel
strategies for neuronal differentiation, but it is also a challenge for
determiningwhich systems best recapitulate the in vivo scenario. If
there are eight diverse protocols for generatingMNs with different
efﬁciencies and purity, should researchers adopt the most efﬁcient
technique to maximize conformity and veriﬁcation of results? Or
does each differentiation technique result in subtle differences that
provide distinct insights into some aspect of neurodevelopment?
In addition to differences in cell culture techniques, there is also
signiﬁcant variability of how researchers present efﬁciency values
in papers. Some calculate efﬁciencies based on a sampling method
that estimates the total number of cells in a culture, some on the
number of neuronal progenitors (i.e., Sox1+ orNestin+ cells), and
some reports are extremely vague about how (or if) they calculate
efﬁciencies or purity. The use of different cell type speciﬁc mark-
ers for quantiﬁcation of derivation and efﬁciency also complicates
comparison of inter-laboratory techniques. These are challenging
questions for the ﬁeld of stem cells in general, but in particular for
neuroscience because of the remarkable diversity of different cell
types in the CNS.
Another issue is how best to study the maturity and function-
ality of PSC-derived neural cells. For certain questions, analyzing
developmental aspects of PSC-derived fate-restricted neural prog-
enitors may be adequate. However, to fully characterize a given
neural subtype, one needs to verify that it canmature and integrate
into the circuitry of a host environment. Simply demonstrating
that cells express cell type speciﬁc (or enriched) genes does not
verify that the cells display similar characteristics to their endoge-
nous counterparts. This daunting task requires several important
considerations: (1) when to isolate cells in the differentiation
process, (2) how, when and where to transplant the cells and/or
plate on adherent substrates or feeder cells (i.e., prepare slices after
transplant and record from labeled cells, etc.). Again, the lack of
conformity due to different laboratories having distinct areas of
expertise makes this a challenging task. However, there is some
push to address these conformity and reproducibility issues using
many different cell lines across multiple laboratories (Boulting
et al., 2011).
The use of PSC-derived neural cells to recapitulate and study
normal and pathological neurodevelopment is clearly a “work-
in progress,” but one of tremendous promise for the ﬁeld of
developmental neurobiology.
ACKNOWLEDGMENTS
We thank Dr. Adam Goulburn and Dr. Takeshi Sakurai for com-
ments on the manuscript. We apologize to all of our colleagues
whose work we did not discuss due to space limitations. This work
was supportedbyNIHgrantsR01MH066912 andRC1MH089690
(Stewart A. Anderson).
REFERENCES
Aboody, K., Capela, A., Niazi, N., Stern,
J. H., and Temple, S. (2011). Trans-
lating stem cell studies to the clinic
for CNS repair: current state of the
art and the need for a rosetta stone.
Neuron 70, 597–613.
Ambasudhan, R., Talantova, M., Cole-
man, R., Yuan, X., Zhu, S., Lipton, S.
A., andDing, S. (2011).Direct repro-
gramming of adult human ﬁbrob-
lasts to functional neurons under
deﬁned conditions. Cell Stem Cell 9,
113–118.
Aubry, L., Bugi, A., Lefort, N., Rousseau,
F., Peschanski, M., and Perrier,
A. L. (2008). Striatal progenitors
derived from human ES cells mature
into DARPP32 neurons in vitro
and in quinolinic acid-lesioned rats.
Proc. Natl. Acad. Sci. U.S.A. 105,
16707–16712.
Bissonnette, C. J., Lyass, L., Bhat-
tacharyya, B. J., Belmadani, A.,
Miller, R. J., and Kessler, J. A. (2011).
The controlled generation of func-
tional Basal forebrain cholinergic
neurons from human embryonic
stem cells. Stem Cells 29, 802–811.
Boulting, G. L., Kiskinis, E., Croft, G.
F., Amoroso, M. W., Oakley, D.
H., Wainger, B. J., Williams, D. J.,
Kahler, D. J., Yamaki, M., Davidow,
L.,Rodolfa,C. T.,Dimos, J. T.,Mikki-
lineni, S., Macdermott, A. B., Woolf,
C. J.,Henderson,C. E.,Wichterle,H.,
and Eggan, K. (2011). A function-
ally characterized test set of human
induced pluripotent stem cells. Nat.
Biotechnol. 29, 279–286.
Brennand, K. J., Simone, A., Jou,
J., Gelboin-Burkhart, C., Tran, N.,
Sangar, S., Li, Y., Mu, Y., Chen,
G., Yu, D., Mccarthy, S., Sebat, J.,
and Gage, F. H. (2011). Modelling
schizophrenia using human induced
pluripotent stem cells. Nature 473,
221–225.
www.frontiersin.org October 2011 | Volume 4 | Article 30 | 9
Petros et al. Stem cells and neural development
Brons, I. G., Smithers, L. E., Trotter, M.
W., Rugg-Gunn, P., Sun, B., Chuva
De Sousa Lopes, S. M., Howlett, S.
K., Clarkson, A., Ahrlund-Richter,
L., Pedersen, R. A., and Vallier, L.
(2007). Derivation of pluripotent
epiblast stem cells from mammalian
embryos. Nature 448, 191–195.
Caiazzo, M., Dell’anno, M. T., Dvoret-
skova, E., Lazarevic, D., Taverna, S.,
Leo, D., Sotnikova, T. D., Mene-
gon, A., Roncaglia, P., Colciago,
G., Russo, G., Carninci, P., Pez-
zoli, G., Gainetdinov, R. R., Gustin-
cich, S., Dityatev, A., and Broc-
coli, V. (2011). Direct generation
of functional dopaminergic neurons
from mouse and human ﬁbroblasts.
Nature 476, 224–227.
Chambers, S. M., Fasano, C. A., Papa-
petrou, E. P., Tomishima, M., Sade-
lain, M., and Studer, L. (2009).
Highly efﬁcient neural conversion
of human ES and iPS cells by dual
inhibition of SMAD signaling. Nat.
Biotechnol. 27, 275–280.
Cundiff, P. E., and Anderson, S. A.
(2011). Impact of induced pluripo-
tent stem cells on the study of central
nervous system disease. Curr. Opin.
Genet. Dev.
Dalton, P. D., andMey, J. (2009). Neural
interactions with materials. Front.
Biosci. 14, 769–795.
Danjo, T., Eiraku, M., Muguruma, K.,
Watanabe, K., Kawada, M., Yana-
gawa, Y., Rubenstein, J. L., and Sasai,
Y. (2011). Subregional speciﬁcation
of embryonic stem cell-derived ven-
tral telencephalic tissues by timed
and combinatory treatment with
extrinsic signals. J. Neurosci. 31,
1919–1933.
Dasen, J. S., and Jessell, T. M. (2009).
Hox networks and the origins of
motor neuron diversity. Curr. Top.
Dev. Biol. 88, 169–200.
Di Giorgio, F. P., Boulting, G. L.,
Bobrowicz, S., and Eggan, K. C.
(2008). Human embryonic stem
cell-derived motor neurons are sen-
sitive to the toxic effect of glial cells
carrying an ALS-causing mutation.
Cell Stem Cell 3, 637–648.
Dimos, J. T., Rodolfa, K. T., Niakan, K.
K., Weisenthal, L. M., Mitsumoto,
H., Chung, W., Croft, G. F., Saphier,
G., Leibel, R., Goland, R., Wichterle,
H., Henderson, C. E., and Eggan,
K. (2008). Induced pluripotent stem
cells generated from patients with
ALS can be differentiated intomotor
neurons. Science 321, 1218–1221.
Ding,S.,Wu,X.,Li,G.,Han,M.,Zhuang,
Y., and Xu, T. (2005). Efﬁcient trans-
position of the piggyBac (PB) trans-
poson inmammalian cells andmice.
Cell 122, 473–483.
Eiraku, M., Takata, N., Ishibashi, H.,
Kawada, M., Sakakura, E., Okuda,
S., Sekiguchi, K., Adachi, T., and
Sasai, Y. (2011). Self-organizing
optic-cup morphogenesis in three-
dimensional culture. Nature 472,
51–56.
Eiraku, M., Watanabe, K., Matsuo-
Takasaki, M., Kawada, M., Yone-
mura, S.,Matsumura,M.,Wataya,T.,
Nishiyama, A., Muguruma, K., and
Sasai, Y. (2008). Self-organized for-
mation of polarized cortical tissues
from ESCs and its active manipula-
tion by extrinsic signals. Cell Stem
Cell 3, 519–532.
Elkabetz,Y., Panagiotakos,G.,Al Shamy,
G., Socci,N. D.,Tabar,V., and Studer,
L. (2008). Human ES cell-derived
neural rosettes reveal a functionally
distinct early neural stem cell stage.
Genes Dev. 22, 152–165.
Erceg, S., Ronaghi, M., Zipancic, I.,
Lainez, S., Rosello, M. G., Xiong, C.,
Moreno-Manzano, V., Rodriguez-
Jimenez, F. J., Planells, R., Alvarez-
Dolado, M., Bhattacharya, S. S., and
Stojkovic,M. (2010). Efﬁcient differ-
entiation of human embryonic stem
cells into functional cerebellar-like
cells. Stem Cells Dev. 19, 1745–1756.
Evans, M. J., and Kaufman, M. H.
(1981). Establishment in culture
of pluripotential cells from mouse
embryos. Nature 292, 154–156.
Fasano, C. A., Chambers, S. M., Lee,
G., Tomishima, M. J., and Studer, L.
(2010). Efﬁcient derivation of func-
tional ﬂoor plate tissue from human
embryonic stem cells. Cell Stem Cell
6, 336–347.
Gaspard, N., Bouschet, T., Herpoel, A.,
Naeije, G., Van Den Ameele, J., and
Vanderhaeghen, P. (2009). Genera-
tion of cortical neurons frommouse
embryonic stem cells. Nat. Protoc. 4,
1454–1463.
Gaspard, N., Bouschet, T., Hourez, R.,
Dimidschstein, J., Naeije, G., Van
Den Ameele, J., Espuny-Camacho,
I., Herpoel, A., Passante, L., Schiff-
mann, S. N., Gaillard, A., and Van-
derhaeghen, P. (2008). An intrinsic
mechanism of corticogenesis from
embryonic stem cells. Nature 455,
351–357.
Gaspard, N., and Vanderhaeghen, P.
(2011). From stem cells to neural
networks: recent advances and per-
spectives for neurodevelopmental
disorders. Dev. Med. Child Neurol.
53, 13–17.
Ghasemi-Mobarakeh, L., Prab-
hakaran, M. P., Morshed, M.,
Nasr-Esfahani, M. H., and Ramakr-
ishna, S. (2008). Electrospun
poly(epsilon-caprolactone)/gelatin
nanoﬁbrous scaffolds for nerve
tissue engineering. Biomaterials 29,
4532–4539.
Ginis, I., Luo, Y., Miura, T., Thies, S.,
Brandenberger, R., Gerecht-Nir, S.,
Amit, M., Hoke, A., Carpenter, M.
K., Itskovitz-Eldor, J., and Rao,M. S.
(2004). Differences between human
and mouse embryonic stem cells.
Dev. Biol. 269, 360–380.
Gore, A., Li, Z., Fung, H. L., Young, J.
E.,Agarwal,S.,Antosiewicz-Bourget,
J., Canto, I., Giorgetti, A., Israel,
M. A., Kiskinis, E., Lee, J. H., Loh,
Y. H., Manos, P. D., Montserrat,
N., Panopoulos, A. D., Ruiz, S.,
Wilbert, M. L., Yu, J., Kirkness, E.
F., Izpisua Belmonte, J. C., Rossi,
D. J., Thomson, J. A., Eggan, K.,
Daley, G. Q., Goldstein, L. S., and
Zhang, K. (2011). Somatic cod-
ing mutations in human induced
pluripotent stem cells. Nature 471,
63–67.
Goulburn, A. L., Alden, D., Davis, R.
P., Micallef, S. J., Ng, E. S., Yu, Q.
C., Lim, S. M., Soh, C. L., Elliott, D.
A., Hatzistavrou, T., Bourke, J., Wat-
muff, B., Lang, R. J., Haynes, J. M.,
Pouton, C. W., Giudice, A., Troun-
son, A. O., Anderson, S. A., Stanley,
E. G., and Elefanty, A. G. (2011). A
targeted NKX2.1 human embryonic
stem cell reporter line enables iden-
tiﬁcation of human basal forebrain
derivatives. Stem Cells 29, 462–473.
Hanna, J. H., Saha, K., and Jaenisch,
R. (2010). Pluripotency and cellular
reprogramming: facts, hypotheses,
unresolved issues.Cell 143, 508–525.
Hochedlinger, K., and Plath, K. (2009).
Epigenetic reprogramming and
induced pluripotency. Development
136, 509–523.
Hockemeyer, D., Soldner, F., Beard, C.,
Gao, Q., Mitalipova, M., Dekelver,
R. C., Katibah, G. E., Amora, R.,
Boydston, E. A., Zeitler, B., Meng,
X., Miller, J. C., Zhang, L., Rebar, E.
J., Gregory, P. D., Urnov, F. D., and
Jaenisch, R. (2009). Efﬁcient target-
ing of expressed and silent genes in
human ESCs and iPSCs using zinc-
ﬁnger nucleases. Nat. Biotechnol. 27,
851–857.
Hussein, S. M., Batada, N. N., Vuoristo,
S., Ching, R. W., Autio, R., Narva, E.,
Ng, S., Sourour,M., Hamalainen, R.,
Olsson, C., Lundin, K., Mikkola, M.,
Trokovic, R., Peitz, M., Brustle, O.,
Bazett-Jones,D. P.,Alitalo,K., Lahes-
maa, R., Nagy, A., and Otonkoski, T.
(2011). Copy number variation and
selection during reprogramming to
pluripotency. Nature 471, 58–62.
Ideguchi,M., Palmer, T. D., Recht, L. D.,
and Weimann, J. M. (2010). Murine
embryonic stem cell-derived pyra-
midal neurons integrate into the
cerebral cortex and appropriately
project axons to subcortical targets.
J. Neurosci. 30, 894–904.
Ikeda, H., Osakada, F., Watanabe, K.,
Mizuseki,K.,Haraguchi,T.,Miyoshi,
H., Kamiya, D., Honda, Y., Sasai,
N., Yoshimura, N., Takahashi, M.,
and Sasai, Y. (2005). Generation
of Rx+/Pax6+ neural retinal pre-
cursors from embryonic stem cells.
Proc. Natl. Acad. Sci. U.S.A. 102,
11331–11336.
Kawasaki, H., Mizuseki, K., Nishikawa,
S., Kaneko, S., Kuwana, Y., Nakan-
ishi, S., Nishikawa, S. I., and Sasai,
Y. (2000). Induction of midbrain
dopaminergic neurons from ES cells
by stromal cell-derived inducing
activity. Neuron 28, 31–40.
Kim, J., Efe, J. A., Zhu, S., Talan-
tova, M., Yuan, X., Wang, S., Lip-
ton, S. A., Zhang, K., and Ding, S.
(2011a). Direct reprogramming of
mouse ﬁbroblasts to neural progeni-
tors. Proc. Natl. Acad. Sci. U.S.A. 108,
7838–7843.
Kim, J. E., O’sullivan, M. L., Sanchez, C.
A., Hwang, M., Israel, M. A., Bren-
nand, K., Deerinck, T. J., Goldstein,
L. S., Gage, F. H., Ellisman, M. H.,
and Ghosh, A. (2011b). Investigat-
ing synapse formation and function
using human pluripotent stem cell-
derived neurons. Proc. Natl. Acad.
Sci. U.S.A. 108, 3005–3010.
Kim, J. H., Auerbach, J. M., Rodriguez-
Gomez, J. A., Velasco, I., Gavin, D.,
Lumelsky, N., Lee, S. H., Nguyen,
J., Sanchez-Pernaute,R.,Bankiewicz,
K., andMckay, R. (2002). Dopamine
neurons derived from embryonic
stem cells function in an animal
model of Parkinson’s disease.Nature
418, 50–56.
Kim, S. U., and de Vellis, J. (2009). Stem
cell-based cell therapy in neurologi-
cal diseases: a review. J. Neurosci. Res.
87, 2183–2200.
Kiris, E., Nuss, J. E., Burnett, J. C.,
Kota, K. P., Koh, D. C., Wanner,
L. M., Torres-Melendez, E., Gus-
sio, R., Tessarollo, L., and Bavari, S.
(2011). Embryonic stem cell-derived
motoneurons provide a highly sen-
sitive cell culture model for bot-
ulinum neurotoxin studies, with
implications for high-throughput
drug discovery. Stem Cell Res 6,
195–205.
Lacoste,A., Berenshteyn, F., and Brivan-
lou, A. H. (2009). An efﬁcient and
reversible transposable system for
gene delivery and lineage-speciﬁc
differentiation in human embryonic
stem cells. Cell Stem Cell 5, 332–342.
Lamba, D. A., Karl, M. O., Ware, C.
B., and Reh, T. A. (2006). Efﬁcient
generation of retinal progenitor cells
from human embryonic stem cells.
Proc. Natl. Acad. Sci. U.S.A. 103,
12769–12774.
Lee, G., Chambers, S. M., Tomishima,
M. J., and Studer, L. (2010). Deriva-
tion of neural crest cells fromhuman
pluripotent stem cells.Nat. Protoc. 5,
688–701.
Frontiers in Molecular Neuroscience | Molecular Neuroscience October 2011 | Volume 4 | Article 30 | 10
Petros et al. Stem cells and neural development
Lee, H., Shamy, G. A., Elkabetz, Y.,
Schoﬁeld, C. M., Harrsion, N. L.,
Panagiotakos, G., Socci, N. D., Tabar,
V., and Studer, L. (2007). Directed
differentiation and transplantation
of human embryonic stem cell-
derivedmotoneurons. Stem Cells 25,
1931–1939.
Lee, S. H., Lumelsky, N., Studer, L.,
Auerbach, J. M., and Mckay, R. D.
(2000). Efﬁcient generation of mid-
brain and hindbrain neurons from
mouse embryonic stem cells. Nat.
Biotechnol. 18, 675–679.
Levine, A. J., and Brivanlou, A. H.
(2007). Proposal of amodel ofmam-
malian neural induction. Dev. Biol.
308, 247–256.
Li, X. J., Du, Z. W., Zarnowska, E. D.,
Pankratz, M., Hansen, L. O., Pearce,
R. A., and Zhang, S. C. (2005).
Speciﬁcation of motoneurons from
human embryonic stem cells. Nat.
Biotechnol. 23, 215–221.
Li, X. J., Zhang, X., Johnson, M. A.,
Wang, Z. B., Lavaute, T., and Zhang,
S. C. (2009). Coordination of sonic
hedgehog and Wnt signaling deter-
mines ventral and dorsal telen-
cephalic neuron types from human
embryonic stem cells. Development
136, 4055–4063.
Lister, R., Pelizzola, M., Kida, Y. S.,
Hawkins, R. D., Nery, J. R., Hon, G.,
Antosiewicz-Bourget, J., O’malley,
R., Castanon, R., Klugman, S.,
Downes, M., Yu, R., Stewart, R.,
Ren, B., Thomson, J. A., Evans,
R. M., and Ecker, J. R. (2011).
Hotspots of aberrant epigenomic
reprogramming in human induced
pluripotent stem cells. Nature 471,
68–73.
Liu, A., and Niswander, L. A. (2005).
Bone morphogenetic protein sig-
nalling and vertebrate nervous sys-
tem development. Nat. Rev. Neu-
rosci. 6, 945–954.
Lombardo, A., Genovese, P., Beause-
jour, C. M., Colleoni, S., Lee, Y. L.,
Kim, K. A., Ando, D., Urnov, F. D.,
Galli, C., Gregory, P. D., Holmes,
M. C., and Naldini, L. (2007). Gene
editing in human stem cells using
zinc ﬁnger nucleases and integrase-
defective lentiviral vector delivery.
Nat. Biotechnol. 25, 1298–1306.
Maden,M. (2006). Retinoids and spinal
cord development. J. Neurobiol. 66,
726–738.
Marchetto,M. C.,Winner, B., and Gage,
F. H. (2010). Pluripotent stem cells
in neurodegenerative and neurode-
velopmental diseases. Hum. Mol.
Genet. 19, R71–R76.
Maroof, A. M., Brown, K., Shi, S.
H., Studer, L., and Anderson, S. A.
(2010). Prospective isolation of cor-
tical interneuron precursors from
mouse embryonic stem cells. J.
Neurosci. 30, 4667–4675.
Martin, G. R. (1981). Isolation of
a pluripotent cell line from early
mouse embryos cultured inmedium
conditioned by teratocarcinoma
stem cells. Proc. Natl. Acad. Sci.
U.S.A. 78, 7634–7638.
Martin, J. H. (2003). Neuroanatomy:
Text and Atlas. New York, NY:
McGraw-Hill.
Miyoshi, N., Ishii, H., Nagano, H.,
Haraguchi, N., Dewi, D. L.,
Kano, Y., Nishikawa, S., Tane-
mura, M., Mimori, K., Tanaka,
F., Saito, T., Nishimura, J., Take-
masa, I., Mizushima, T., Ikeda,
M., Yamamoto, H., Sekimoto, M.,
Doki, Y., and Mori, M. (2011).
Reprogramming of mouse and
human cells to pluripotency using
mature microRNAs. Cell Stem Cell
8, 633–638.
Munoz-Sanjuan, I., and Brivanlou,
A. H. (2002). Neural induction,
the default model and embryonic
stem cells. Nat. Rev. Neurosci. 3,
271–280.
Muotri, A. R., Nakashima, K., Toni,
N., Sandler, V. M., and Gage, F.
H. (2005). Development of func-
tional human embryonic stem cell-
derived neurons in mouse brain.
Proc. Natl. Acad. Sci. U.S.A. 102,
18644–18648.
Murashov, A. K., Pak, E. S., Hendricks,
W. A., Owensby, J. P., Sierpinski,
P. L., Tatko, L. M., and Fletcher,
P. L. (2005). Directed differentia-
tion of embryonic stem cells into
dorsal interneurons. FASEB J. 19,
252–254.
Nistor, G., Seiler, M. J., Yan, F.,
Ferguson, D., and Keirstead, H.
S. (2010). Three-dimensional early
retinal progenitor 3D tissue con-
structs derived from human embry-
onic stem cells. J. Neurosci. Methods
190, 63–70.
O’Leary, D. D., Chou, S. J., and
Sahara, S. (2007). Area patterning of
the mammalian cortex. Neuron 56,
252–269.
Osakada, F., Ikeda, H., Mandai, M.,
Wataya,T.,Watanabe,K.,Yoshimura,
N., Akaike, A., Sasai, Y., and Taka-
hashi, M. (2008). Toward the gen-
eration of rod and cone photore-
ceptors from mouse, monkey and
human embryonic stem cells. Nat.
Biotechnol. 26, 215–224.
Pang, Z. P., Yang, N., Vierbuchen,
T., Ostermeier, A., Fuentes, D. R.,
Yang, T. Q., Citri, A., Sebastiano,
V., Marro, S., Sudhof, T. C., and
Wernig, M. (2011). Induction of
human neuronal cells by deﬁned
transcription factors. Nature 476,
220–223.
Partanen, J. (2007). FGF signalling path-
ways in development of the mid-
brain and anterior hindbrain. J.Neu-
rochem. 101, 1185–1193.
Patani, R., Hollins, A. J., Wishart, T.
M., Puddifoot, C. A., Alvarez, S., De
Lera, A. R., Wyllie, D. J., Compston,
D. A., Pedersen, R. A., Gillingwa-
ter, T. H., Hardingham, G. E., Allen,
N. D., and Chandran, S. (2011).
Retinoid-independent motor neu-
rogenesis from human embryonic
stem cells reveals a medial colum-
nar ground state. Nat. Commun.
2, 214.
Peljto, M., Dasen, J. S., Mazzoni, E.
O., Jessell, T. M., and Wichterle,
H. (2010). Functional diversity of
ESC-derived motor neuron sub-
types revealed through intraspinal
transplantation. Cell Stem Cell 7,
355–366.
Pera, M. F., Andrade, J., Houssami, S.,
Reubinoff, B., Trounson, A., Stan-
ley, E. G., Ward-Van Oostwaard, D.,
and Mummery, C. (2004). Regu-
lation of human embryonic stem
cell differentiation by BMP-2 and its
antagonist noggin. J. Cell. Sci. 117,
1269–1280.
Perrier, A. L., Tabar, V., Barberi, T.,
Rubio, M. E., Bruses, J., Topf,
N., Harrison, N. L., and Studer,
L. (2004). Derivation of midbrain
dopamine neurons from human
embryonic stem cells. Proc. Natl.
Acad. Sci. U.S.A. 101, 12543–12548.
Pﬁsterer, U., Kirkeby, A., Torper, O.,
Wood, J., Nelander, J., Dufour, A.,
Bjorklund, A., Lindvall, O., Jakobs-
son, J., andParmar,M. (2011).Direct
conversion of human ﬁbroblasts to
dopaminergic neurons. Proc. Natl.
Acad. Sci. U.S.A. 108, 10343–10348.
Placantonakis, D. G., Tomishima, M. J.,
Lafaille, F., Desbordes, S. C., Jia, F.,
Socci, N. D., Viale, A., Lee, H., Har-
rison, N., Tabar, V., and Studer, L.
(2009). BAC transgenesis in human
embryonic stem cells as a novel tool
to deﬁne the human neural lineage.
Stem Cells 27, 521–532.
Pruszak, J., Sonntag, K. C., Aung,
M. H., Sanchez-Pernaute, R., and
Isacson, O. (2007). Markers and
methods for cell sorting of human
embryonic stem cell-derived neural
cell populations. Stem Cells 25,
2257–2268.
Qiang, L., Fujita, R., Yamashita, T.,
Angulo, S., Rhinn, H., Rhee, D.,
Doege, C., Chau, L., Aubry, L.,
Vanti, W. B., Moreno, H., and Abe-
liovich, A. (2011). Directed conver-
sion of Alzheimer’s disease patient
skin ﬁbroblasts into functional neu-
rons. Cell 146, 359–371.
Roy, N. S., Cleren, C., Singh, S. K.,
Yang, L., Beal, M. F., and Goldman,
S.A. (2006). Functional engraftment
of human ES cell-derived dopamin-
ergic neurons enriched by cocul-
ture with telomerase-immortalized
midbrain astrocytes. Nat. Med. 12,
1259–1268.
Salero, E., and Hatten, M. E. (2007).
Differentiation of ES cells into cere-
bellar neurons. Proc. Natl. Acad. Sci.
U.S.A. 104, 2997–3002.
Shen, L., Nam, H. S., Song, P., Moore,
H., and Anderson, S. A. (2006).
FoxG1 haploinsufﬁciency results in
impaired neurogenesis in the post-
natal hippocampus and contextual
memory deﬁcits. Hippocampus 16,
875–890.
Sidhu, K. S. (2011). New approaches for
the generation of induced pluripo-
tent stem cells. Expert Opin. Biol.
Ther. 11, 569–579.
Smith, J. R., Vallier, L., Lupo, G.,
Alexander, M., Harris, W. A., and
Pedersen, R. A. (2008). Inhibition
of activin/nodal signaling promotes
speciﬁcation of human embryonic
stem cells into neuroectoderm. Dev.
Biol. 313, 107–117.
Smukler, S. R., Runciman, S. B., Xu,
S., and Van Der Kooy, D. (2006).
Embryonic stem cells assume a
primitive neural stem cell fate in
the absence of extrinsic inﬂuences.
J. Cell Biol. 172, 79–90.
Son, E. Y., Ichida, J. K., Wainger,
B. J., Toma, J. S., Rafuse, V. F.,
Woolf, C. J., and Eggan, K. (2011).
Conversion of mouse and human
ﬁbroblasts into functional spinal
motor neurons. Cell Stem Cell 9,
205–218.
Soundararajan,P.,Miles,G. B.,Rubin,L.
L., Brownstone, R. M., and Rafuse,
V. F. (2006). Motoneurons derived
from embryonic stem cells express
transcription factors and develop
phenotypes characteristic of medial
motor column neurons. J. Neurosci.
26, 3256–3268.
Stadtfeld, M., and Hochedlinger, K.
(2010). Induced pluripotency: his-
tory, mechanisms, and applications.
Genes Dev. 24, 2239–2263.
Stern, C. D. (2005). Neural induc-
tion: old problem, new ﬁndings, yet
more questions. Development 132,
2007–2021.
Su, H. L., Muguruma, K., Matsuo-
Takasaki, M., Kengaku, M., Watan-
abe, K., and Sasai,Y. (2006). Genera-
tion of cerebellar neuron precursors
fromembryonic stemcells.Dev. Biol.
290, 287–296.
Takahashi, K., Tanabe, K., Ohnuki, M.,
Narita, M., Ichisaka, T., Tomoda, K.,
and Yamanaka, S. (2007). Induc-
tion of pluripotent stem cells from
adult human ﬁbroblasts by deﬁned
factors. Cell 131, 861–872.
www.frontiersin.org October 2011 | Volume 4 | Article 30 | 11
Petros et al. Stem cells and neural development
Takahashi, K., and Yamanaka, S. (2006).
Induction of pluripotent stem cells
from mouse embryonic and adult
ﬁbroblast cultures by deﬁned fac-
tors. Cell 126, 663–676.
Talens-Visconti, R., Sanchez-Vera, I.,
Kostic, J., Perez-Arago, M. A., Erceg,
S., Stojkovic, M., and Guerri, C.
(2011). Neural differentiation from
human embryonic stem cells as a
tool to study early brain devel-
opment and the neuroteratogenic
effects of ethanol. Stem Cells Dev. 20,
327–339.
Tao, O., Shimazaki, T., Okada, Y., Naka,
H., Kohda, K., Yuzaki, M., Mizu-
sawa,H., andOkano,H. (2010). Efﬁ-
cient generationofmature cerebellar
Purkinje cells from mouse embry-
onic stem cells. J. Neurosci. Res. 88,
234–247.
Tesar, P. J., Chenoweth, J. G., Brook, F.
A., Davies, T. J., Evans, E. P., Mack,
D. L., Gardner, R. L., and Mckay, R.
D. (2007).New cell lines frommouse
epiblast share deﬁning features with
human embryonic stem cells.Nature
448, 196–199.
Thomson, J. A., Itskovitz-Eldor, J.,
Shapiro, S. S., Waknitz, M. A.,
Swiergiel, J. J., Marshall, V. S., and
Jones, J. M. (1998). Embryonic stem
cell lines derived from human blas-
tocysts. Science 282, 1145–1147.
Ting, D. T., Kyba, M., and Daley, G. Q.
(2005). “Inducible transgene expres-
sion inmouse stem cells,” inMethods
in Molecular Medicine: Developmen-
tal Hematopoiesis Methods and Pro-
tocols, ed. M. H. Baron (Totowa, NJ:
Humana Press, Inc.), 23–46.
Tomishima,M. J., Hadjantonakis, A. K.,
Gong, S., and Studer, L. (2007). Pro-
duction of green ﬂuorescent pro-
tein transgenic embryonic stem cells
using theGENSATbacterial artiﬁcial
chromosome library. Stem Cells 25,
39–45.
Tropepe, V., Hitoshi, S., Sirard, C., Mak,
T. W., Rossant, J., and Van Der Kooy,
D. (2001). Direct neural fate speci-
ﬁcation from embryonic stem cells:
a primitive mammalian neural stem
cell stage acquired through a default
mechanism. Neuron 30, 65–78.
Ulloa, F., andMarti, E. (2010).Wnt won
the war: antagonistic role of Wnt
over Shh controls dorso-ventral pat-
terning of the vertebrate neural tube.
Dev. Dyn. 239, 69–76.
Vierbuchen, T., Ostermeier, A., Pang, Z.
P., Kokubu, Y., Sudhof, T. C., and
Wernig, M. (2010). Direct conver-
sion of ﬁbroblasts to functional neu-
rons by deﬁned factors. Nature 463,
1035–1041.
Watanabe, K., Kamiya, D., Nishiyama,
A., Katayama, T., Nozaki, S.,
Kawasaki, H., Watanabe, Y.,
Mizuseki, K., and Sasai, Y. (2005).
Directed differentiation of telen-
cephalic precursors from embryonic
stem cells.Nat. Neurosci. 8, 288–296.
Watanabe, K., Ueno, M., Kamiya,
D., Nishiyama, A., Matsumura,
M., Wataya, T., Takahashi, J. B.,
Nishikawa, S., Muguruma, K., and
Sasai, Y. (2007). A ROCK inhibitor
permits survival of dissociated
human embryonic stem cells. Nat.
Biotechnol. 25, 681–686.
Wataya, T., Ando, S., Muguruma, K.,
Ikeda, H., Watanabe, K., Eiraku,
M., Kawada, M., Takahashi, J.,
Hashimoto, N., and Sasai, Y. (2008).
Minimization of exogenous signals
in ES cell culture induces ros-
tral hypothalamic differentiation.
Proc. Natl. Acad. Sci. U.S.A. 105,
11796–11801.
Wernig, M., Benninger, F., Schmandt,
T., Rade, M., Tucker, K. L., Bussow,
H., Beck, H., and Brustle, O. (2004).
Functional integration of embryonic
stem cell-derived neurons in vivo. J.
Neurosci. 24, 5258–5268.
Wichterle, H., Lieberam, I., Porter, J. A.,
and Jessell, T. M. (2002). Directed
differentiation of embryonic stem
cells into motor neurons. Cell 110,
385–397.
Wobus, A. M., and Loser, P. (2011).
Present state and future perspectives
of using pluripotent stem cells in
toxicology research.Arch.Toxicol.85,
79–117.
Yan, Y., Yang, D., Zarnowska, E. D.,
Du, Z., Werbel, B., Valliere, C.,
Pearce, R. A., Thomson, J. A., and
Zhang, S. C. (2005). Directed dif-
ferentiation of dopaminergic neu-
ronal subtypes from human embry-
onic stem cells. Stem Cells 23,
781–790.
Ying, Q. L., Stavridis, M., Grifﬁths,
D., Li, M., and Smith, A. (2003).
Conversion of embryonic stem cells
into neuroectodermal precursors in
adherentmonoculture.Nat. Biotech-
nol. 21, 183–186.
Yoo, A. S., Sun, A. X., Li, L., Shche-
glovitov, A., Portmann, T., Li, Y.,
Lee-Messer, C., Dolmetsch, R. E.,
Tsien, R. W., and Crabtree, G. R.
(2011). MicroRNA-mediated con-
version of human ﬁbroblasts to neu-
rons. Nature 476, 228–231.
Yu, J., Vodyanik, M. A., Smuga-Otto, K.,
Antosiewicz-Bourget, J., Frane, J. L.,
Tian, S., Nie, J., Jonsdottir, G. A.,
Ruotti, V., Stewart, R., Slukvin, I.,
and Thomson, J. A. (2007). Induced
pluripotent stem cell lines derived
from human somatic cells. Science
318, 1917–1920.
Yusa, K., Zhou, L., Li, M. A., Bradley, A.,
and Craig, N. L. (2011). A hyperac-
tive piggyBac transposase for mam-
malian applications. Proc. Natl.
Acad. Sci. U.S.A. 108, 1531–1536.
Zhang, X., Huang, C. T., Chen, J.,
Pankratz, M. T., Xi, J., Li, J., Yang,
Y., Lavaute, T. M., Li, X. J., Ayala, M.,
Bondarenko, G. I., Du, Z. W., Jin, Y.,
Golos,T. G., andZhang, S. C. (2010).
Pax6 is a human neuroectoderm cell
fate determinant. Cell Stem Cell 7,
90–100.
Zhao, C., Deng, W., and Gage, F. H.
(2008). Mechanisms and functional
implications of adult neurogenesis.
Cell 132, 645–660.
Conﬂict of Interest Statement: The
authors declare that the research was
conducted in the absence of any
commercial or ﬁnancial relationships
that could be construed as a potential
conﬂict of interest.
Received: 05 July 2011; accepted: 23 Sep-
tember 2011; published online: 12 Octo-
ber 2011.
Citation: Petros TJ, Tyson JA and
Anderson SA (2011) Pluripotent stem
cells for the study of CNS develop-
ment. Front. Mol. Neurosci. 4:30. doi:
10.3389/fnmol.2011.00030
This article was submitted to Frontiers
in Molecular Neuroscience, a specialty of
Frontiers in Molecular Neuroscience.
Copyright © 2011 Petros, Tyson and
Anderson. This is an open-access arti-
cle subject to a non-exclusive license
between the authors and Frontiers Media
SA, which permits use, distribution and
reproduction in other forums, provided
the original authors and source are cred-
ited and other Frontiers conditions are
complied with.
Frontiers in Molecular Neuroscience | Molecular Neuroscience October 2011 | Volume 4 | Article 30 | 12
